Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.24
+0.96 (10.34%)
Aug 14, 2026, 3:45 PM EDT - Market open
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $636.5 million as of August 14, 2026. Its market cap has increased by 104.30% in one year.
Market Cap
636.50M
Enterprise Value
380.88M
1-Year Change
104.30%
Ranking
Category
Stock Price
$10.24
ChartMarket Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has increased from $354.80M to $636.50M, an increase of 79.40%. That is a compound annual growth rate of 20.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 636.50M | 230.60% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 605.75M |
| Verastem | 604.06M |
| Autolus Therapeutics | 590.84M |
| Arvinas | 589.13M |
| Assembly Biosciences | 576.57M |
| Contineum Therapeutics | 575.60M |
| Prime Medicine | 563.96M |
| Altimmune | 560.21M |